Profile of the leucogram in patients with schizophrenia refractory using clozapine
DOI:
https://doi.org/10.33448/rsd-v9i3.2352Keywords:
Schizophrenia; Clozapine; Blood count.Abstract
Schizophrenia is a chronic mental illness quite present in Brazilian society, but it does not have the care and attention necessary to make the patient's well-being satisfactory. It has a very complex pharmacodynamics, where without proper care, can cause adverse effects that may harm the health of the patient. Therefore, the objective of this study is to evaluate in the last five years the leukogram profile of patients with refractory schizophrenia who use clozapine assisted in the Specialized Component of Pharmaceutical Care of Piauí, by analyzing data that will be collected through the evaluation of medical records. analyzing and verifying that the leukogram levels of these patients are within the parameters recommended by the literature. They were then checked in the SOFTWARE PRISMA 6.0 program. The results showed that of the analyzed charts, regarding gender, 64% were men and 36% were women. There was an incidence of agranulocytosis and the highest age was 31 to 40 years. Drug change and the incidence of neutropenia, thrombocytopenia and eosinophilia were also observed in some patients. Thus, it can be suggested that patients with refractory schizophrenia treated in the Specialized Component of Pharmaceutical Care of Piauí, are having a multiprofessional follow-up, especially the pharmacist who provides patient care at the time of dispensation, very effective.
References
Abamny, N.O., Al-jaloud, A., Al-jabr, A., Al-ruwaisan, R., Al-saeed, W., Fatani, S. (2014). Clozapine-induced blood dyscrasias in Saudi Arab patients. International Journal of Clinical Pharmacy. 36(4): 815-820.
Aydin, M., Ilhan, B.C., Calisir, S., Yildirim, S., Eren, I. (2016). Continuing clozapine treatment with lithium in schizophrenic with neutropenia or leukopenia: brief review of literature with case reports. Therapeutic Advances in Psychopharmacology. 6(1): 33-38.
Balda, M., Garay, O.U., Papale, R.M., Bignone, I., Bologna, V.G., Brandolini, A., Prokopez, C.R., Balasini, J.L., Baldessarini, R.J., Daray, F.M. (2015). Clozapineassociated neutropenia and agranulocytosis in Argentina (2007-2012). International Clinical Psychopharmacology. 30(2): 109-114.
Chaves, A.C. (1994). Diferenças entre os sexos na evolução da esquizofrenia [dissertação]. São Paulo: Escola Paulista de Medicina.
Demler, T.L., Trigoboff, E. (2011). Are clozapine blood dyscrasias associated with concomitant medications? Innovations in Clinical Neuroscience. 8(4): 35-41.
Failace, R. (2015). Hemograma, Manual de Interpretação. 6. ed. Porto Alegre: Artmed, 482 p.
Fonseca, J. J. S. (2002). Metodologia da pesquisa científica. Fortaleza: UEC.
Gama, C.S., Souza, C.M., Lobato, M.I, Abreu, P.S.B. Clozapine use report in 56 patients seen by Clerkship of Health and Environment of the State of Rio Grande do Sul’s Program of Attention to the Refractory Schizophrenia. Rev Psiquiatr Rio Grande Sul. 2004; 26(1):21-8. doi: 10.1590/ S0101-81082004000100004.
Gerhardt, T.E., Lopes, M.J.M., Roese, A., Souza, A. (2005). A construção e a utilização do diário de campo em pesquisas científicas. International Journal of Qualitative Methods.
Gil, A. C. (2007). Métodos e técnicas de pesquisa social. São Paulo: Atlas, 1999. Como elaborar projetos de pesquisa. 4. ed. São Paulo: Atlas.
Goldstein, J.M. (1995). The impact of gender in understanding the epidemiology of schizophrenia. In: Seeman MV, editor. Gender and psychopathology. Washington (DC): American Psychiatry Press. p. 159-99.
Graeff, F. G. (1989). Antipsicóticos. In Drogas psicotrópicas e seu modo de ação (pp. 21- 39). São Paulo: E.P.U.
Graeff, F.G., Guimarães, F.S. (1999). Medicamentos antipsicóticos. In F.G. Graeff, F.S. Guimarães & A. V. Zuardi (Org.), Fundamentos de psicofarmacologia (pp. 69-91). São Paulo: Atheneu.
Grotto, H.Z.W. (2009). O hemograma: importância para interpretação da biopsia. Revista Brasileira de Hematologia e Hemoterapia; São Paulo.
Häffner, H., Heider, W., Behrens, S., Gattaz, W.F., Hambrecht, M., Löffler, W., et al. (1998). Causes and consequences of the gender difference in age at onset of schizophrenia. Schizo Bull. 24(2):99-113.
Honigfel, G., Arellano, F., Sethi, J., Bianchini, A., Schein, S. Reduced clozapina related morbidity and mortality: five year experience with the clozaril National Resgistry. J Clin Psychiatry 1998;59:3-7.
Jann, M.W. (1991). Clozapine. Pharmacoterapy. 11(3):179-95.
Kane, J.M., Honigfeld, G., Singer, J., Meltzer, H.Y. (1988). Clozapine for the treatmentresistant schizophrenic: A double blind comparison with Chlorpromazine. Archives Of General Psychiatry. 45:789-796.
Lehman, A.F., Lieberman, J.A., Dixon, L.B., Mcglashan, T.H., Miller, A.L., Perkins, D.O., Kreyenbuhl, J. (2004). American Psychiatry Association; Steering Committee on Practice Guidelines. Practice guideline for the treatment of patients with schizophrenia, second edition. The American Journal of Psychiatry.161(2 Suppl):1-56.
Lieberman, J. (1994). Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome. The American Journal of Psychiatry. 151;12.
McEwen, B.S. (1991). Sex differences in the brain: what they are and how they arise. In: Notman MT, Nadelson CC, editors. Women and Men: New perspectives on gender differences. Washington (DC): American Psychiatric Press; p. 35-42.
Morais, R.M.O., Oliveira, I.R. Antipsicóticos. In: Silva P. Farmacologia. 7a. ed. Rio de Janeiro: Guanabara Koogan; 2006.
Nykiel, S., Handerson, D., Bhide, G., Freudenreich, O. (2010). Lithium to allow clozapine prescribing in benign ethnic neutropenia. Clinical Schizophrenia & Related Psychoses. 4(2): 138-40.
Oliveira, R.A.G. (2007). Hemograma: Como fazer e interpretar. São Paulo: Livraria Médica Paulista Editora.
Pons, A., Undurraga, J., Bernanrdo, M. (2012). Clozapine and agranulocytosis in Spain: Do we have a safer population? A 5-year hematologic follow-up. Revista de Psiquiatria y salud mental (Barc.) 5(1): 37-42.
Raja, M.; Raja, S. (2014). Clozapine safety, 40 years later. Current Drug Safety. 9(3): 163- 95.
Seeman, M.V. (1990). Lang M. The role of estrogens in schizophrenia gender differences. Schizophr Bull;16:185-94.
Shad, M. (2008). Clozapine toxicity: A discussion of pharmacokinetic factors. Asian Journal of Psychiatry. 35: 47-49.
Tandon, R., Nasrallah, H., Keshavan, M. (2010). Schizophrenia, “just the facts”. Treatment and prevention. Past, present, and future. Schizophrenia Res, 122: 1-23.
Timoteo, M. D. O. (2008). Estudo de bioequivalência da clozapina em pacientes psicóticos no estado de equilíbrio. Universidade Federal Fluminense.
Villares, Cecília., Redko, Cristina., Mari, Jair. Concepções de doença por familiares de pacientes com diagnóstico de esquizofrenia. Online. Disponível em: <http://www.scielo.br/pdf/%0D/rbp/v21n1/v21n1a08.pdf>. Acesso em: 2019.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
